Adult Immunization

Your daily dose of the clinical news you may have missed.

New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.

Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.

The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.

The new data amend that from prelicensure trials, which did not include fair representation of older adults and others more vulnerable to severe RSV disease.

The Bridge Access Program allowed Americans who are uninsured or underinsured to receive COVID-19 vaccination at not cost and was ended abruptly last month.

The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.

PfizerForAll offers telehealth and prescription services, vaccination scheduling and savings programs, and is partnering with recognized companies such as InstaCart.

Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.

Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.